CRVS ▲ +1.7% - Corvus Pharmaceuticals, Inc.
$CRVS - Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68?? American Society for Hematology Annual Meeting & Exposition
04-NOV-2026 09:01 AM ET
Share this post
More filings for $CRVS
CRVS ▼ -0.4% - Corvus Pharmaceuticals, Inc.Oct 29, 2026CRVS ▼ -0.5% - Corvus Pharmaceuticals, Inc.Sep 30, 2026CRVS ▼ -0.3% - Corvus Pharmaceuticals, Inc.Sep 3, 2026CRVS ▼ -0.6% - Corvus Pharmaceuticals, Inc.Aug 27, 2026CRVS - Corvus Pharmaceuticals, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026$CRVS SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $CRVS filing history →💬 Comments
Loading comments…
Leave a comment